SNY - Sanofi Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 AAPL (0%) VXX (0%) SPY (0%) UGAZ (0%) EOSUSD (%) AMZN (0%) EXPR (0%) ETHUSD (%) ABMD (0%) MDB (0%) MARA (0%) M (0%) LTCUSD (%) JNPR (0%) JNCE (0%) IPI (0%) HST (0%) GME (0%) FTSV (%) DPW (0%) DLTR (0%) DFFN (0%) CVX (0%) CGC (0%) BNGO (0%)

SNY - Sanofi

$48.09 0[0%]

15 mins delayed data

People also watch :

+Watchlist

2 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$48.09	Open
Volume	17.6K	Market Cap	115.339B
Yield	0.0374%	Last Dividend	$1.72

Day

52 Week

Sanofi (SNY) Looks Good: Stock Adds 6.2%...	5:30 AM
Sanofi (SNY) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Sanofi to restructure Newton diabetes st...	2:29 AM
Sanofi’s new CEO laid out plans Tuesday to shake up one of the Bay State’s biggest drug companies, potentially throwing its 3-year-old diabetes-focuse...

Why Biotech ETFs are Surging to New High...	12/10/19
increasing M&A deals and cutting edge therapies are driving biotech ETFs higher

Why This Pharmaceutical Stock Broke Out ...	12/10/19
SNY stock broke out Tuesday after pharmaceutical company unveiled a plan to restructure its agreement with Regeneron Pharmaceuticals. Sanofi will also...

Regeneron Shares Swing On Sanofi's Hint ...	12/10/19
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) shares were rebounding Tuesday as investors digested French pharma giant and collaboration partner Sanofi...

Biotech ETFs Hit New Highs on Deal Activ...	12/10/19
Following the new deals in the healthcare space, a few biotech ETFs hit new highs.

Merck to Buy ArQule for $2.7B to Boost C...	12/10/19
Merck (MRK) offers to acquire ArQule for a deal value of $2.7 billion. The transaction will add ArQule's lead investigational candidate ARQ 531 to...

Regeneron shares fall on Sanofi's ne...	12/10/19
Sanofi and Regeneron Pharmaceuticals announced plans to restructure two drug-development collaborations after Sanofi announced a new direction for t...

Sanofi Unveils Growth Strategy, Ends Dia...	12/10/19
Sanofi (SNY) to prioritize key growth drivers, improve operating efficiencies and generate cost savings. The company discontinues R&D activities in di...

Pharma M&As Continue, Merck, Sanofi ...	12/10/19
Merck offers to buy ArQule for $2.7 billion while Sanofi signs a definitive deal to purchase Synthorx for $2.5 billion.

Dow Jones Futures: Stock Market, Apple O...	12/10/19
Dow futures and Apple fell as the stock market still awaits China trade war clarity from President Trump on Dec. 15 tariffs. MongoDB, Stitch Fix, Boei...

ANALYST RATINGS

1 analyst ratings (Last 6 months)

100.00 %

Strong Buy + Buy

Price Target (PT)

Strong Buy rating	09/03/19
Bernstein initiates coverage with Outperform rating and announces Price Target of $52.00

EARNINGS

Date	2019-10-31 (BMO)	Est. (EPS/Rev.)	$0.96/ 10.38B
Actual (EPS/Rev.)	$2.09/ $10.35 B	EPS (TTM)	1.65

TRADERS TRACKING $SNY

Service Name	Trader	% Success
Kiplinger - JAMES K. GLASSMAN	StockHoot	70.00 %	Follow
1035even	Evan Earle	61.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.